U9Z-29547-04819
1 vaccination
1 coded response
6 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 152 / PA
- Registered
- 2022-05-16
- Relationship
- Child or adolescent in my care
- Guardian
- 9GP-27266-99247
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-05-09
Dose 1 — Pfizer-BioNTech
-
2022-05-16
Registered in v-safe
- 2022-05-16
-
2022-05-23
Survey response — day 14, dose 1, dependentMedDRA: Cough, Dyspnoea, Fatigue, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: cough, SOB, fatigue, feverMedDRA releases: 2024-11 · check-in free text available
- 2022-05-30
- 2022-08-08
- 2022-11-07
- 2023-05-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-05-09 | Pfizer-BioNTech | No |
Free text
Release 11 — day 14, dose 1, dependent
Symptoms: cough, SOB, fatigue, fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release